| 1861 |
EVRON 35 |
ETHINYLESTRADIOL BP 0.035 MG, CYPROTERONEACETATE BP 2 MG |
TABLETS |
PVC BLISTER |
TREATMENT OF MODERATE TO SEVERE ACNE RELATED TO ANDROGEN SENSITIVITY (WITH OR WITHOUT SEBORRHOEA) AND/OR HIRSUTISM, IN WOMEN OF REPRODUCTIVE AGE |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICALS &DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
01 I 5672/24 |
26-JAN-2024 |
25-JAN-2027 |
View |
| 1862 |
EVRON DESO |
DESOGESTREL USP 0.15 MG, ETHINYL ESTRADIOL USP 0.03 MG |
TABLET |
PVC BLISTER |
ORAL CONTRACEPTION |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICALS &DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
05 I 5491/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
| 1863 |
EVRON DESO POP |
DESOGESTREL 0.075 MG |
TABLETS |
PVC BLISTER |
FOR PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE THIS PRODUCT AS A METHOD OF CONTRACEPTION |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICALS &DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
01 I 5673/24 |
26-JAN-2024 |
25-JAN-2027 |
View |
| 1864 |
EVRON GEST 200 SR |
PROGESTERONE USP (NATERAL MICRONIZED) 200 MG |
TABLETS |
ALU-PVC BLISTER |
PREMENSTRUAL SYNDROME, MENSTRUAL IRREGULARITIES THROUGH DYSOVULATION OR ANOVULATION, MENOPAUSE (IN ADDITION TO OESTROGEN TREATMENT) TO SIGNIFICANTLY REDUCETHE RISK OF ENDOMETRIAL HYPERPLASIA AND CARCINOMA, DYSFUNCTIONAL UTRINE BLEEDING, SECONDARY AMENORRHOEA, LUTEAL SUPPORT DURING ASSITED REPRODUCTIVE TECHNIQUE, LUTEAL SUPPORT IN LUTEAL PHASE DEFECT |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICALS &DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
01 I 5674/24 |
26-JAN-2024 |
25-JAN-2027 |
View |
| 1865 |
EVRON MISO 200 |
MISOPROSTOL USP 200 MCG |
TABLET |
ALU-ALU BLISTER |
FOR THE HEALING OF DUODENAL ULCER AND GASTRIC ULCER INCLUDING THOSE INDUCED BY NSAID IN ARTHRITIC PATIENTS AT RISK, WHILST CONTINUING THEIR NSAID THERAPY. |
NULL |
MEMESCO CO.,LTD |
ACCENT PHARMACEUTICALS &DIAGNOSTICS |
INDIA |
CERTIFICATE RELEASED |
05 I 5492/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
| 1866 |
FROTIN PESSARIES 250 MG |
METRONIDAZOLE 250 MG |
PESSARY |
STRIP |
FOR THE TREATMENT OF VAGINITIS CAUSED BY TRICHOMONAS VAGINALIS |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 3137/08 |
07-FEB-2024 |
06-FEB-2027 |
View |
| 1867 |
FUCON FILM COATED TABLET 10 MG |
HYOSCINE BUTYLBROMIDE 10 MG |
FILM COATED TABLET |
ALU-PVC BLISTER |
FOR THE TREATMENT OF SPASMODIC PAIN, ESOPHAGEAL SPASM, CHOLECYSTITIS, CHOLEDOCHOLITHIASIS, URIASIS CYSTOSPASM, DYSURIA, POLLAKISURIA, AND SPASMODIC DYSMENORRHEA |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
07 I 5577/23 |
07-JUL-2023 |
06-JUL-2026 |
View |
| 1868 |
FUCON SYRUP 1 MG/ML |
HYOSCINE BUTYLBROMIDE 1 MG/ML |
SYRUP |
BOTTLE |
GASTROINTESTINAL TRACT SPASM, SPASM AND DYSKINESIA OF THE BILIARY SYSTEM, GENITO-URINARY TRACT SPASM |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
10 I 4999/20 |
07-FEB-2024 |
06-FEB-2027 |
View |
| 1869 |
FUKOLE |
FLUCONAZOLE 150MG |
CAPSULE |
ALU-PVC BLISTER |
TREATMENT AND PREVENTION OF CRYPTOCOCCAL MENINGITIS AND OTHER CRYPTOCOCCAL INFECTIONS; TREATMENT OF VAGINAL, OROPHARYNGEAL AND OTHER FORMS OF CANDIDIASIS; PREVENTION OF FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS |
NULL |
MEMESCO CO.,LTD |
Y.S.P. INDUSTRIES (M) SDN.BHD |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 3316/09 |
28-APR-2023 |
27-APR-2026 |
View |
| 1870 |
FUROCEF 250 MG |
CEFUROXIME AXETIL USP 304.878 MG EQ.TO CEFUROXIME 250 MG |
FILM COATED TABLET |
ALU-ALU BLISTER PACK |
PHARYNGITIS/TONSILLITIS, ACUTE BACTERIAL OTITIS MEDIA, ACUTE BACTERIAL MAXILLAR SINUSITIS, ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS AND SECONDARY BACTERIAL INFECTIONS OF ACUTE BRONCHITIS, UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTION, UNCOMPLICATED URINARY TRACT INFECTION, UNCOMPLICATED GONORRHEA, URETHRAL AND ENDOCERVICAL, EARLY LYME DISEASE |
NULL |
MEMESCO CO.,LTD |
RENATA LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
10 I 5620/23 |
17-OCT-2023 |
16-OCT-2026 |
View |
